Patients can start with a lower dose and gradually increase it, providing a more personalized approach to weight management
Semaglutide (Wegovy), in both its oral and injectable forms, has also been approved to treat the liver condition MASH
Semaglutide Functions primarily as a GLP-1 receptor agonist Helps regulate appetite and satiety Widely used in medical weight-loss programs Tirzepatide Targets both GLP-1 and GIP pathways Provides dual hormone activity May produce greater average weight loss in some patients The best option depends on several factors, including medical history, treatment goals, medication tolerance, and provider recommendations
Digestion Changes: By slowing down digestion, GLP-1 RAs may affect how well your body absorbs some vitamins and minerals
Get on it, its worth it. The symptoms of the injectable and pill versions are similar
J.KatsumotoA.TeixeiraA